NFKB1 and nasopharyngeal carcinoma: This observation of impaired innate and adaptive immunity supports the notion that NPC tumors are protected by both viral and somatic mechanisms of immune evasion in patients, representing the second viral-somatic co-selected mechanisms (after NF-κB activation) for NPC tumorigenesis.